Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-814-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2000-07-11 to 2000-08-17
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- Species : Dunkin Hartley strain, albino guinea pig (SPF-quality). Recognised by international guidelines as the recommended test system (e.g. OECD, EC).
Source : Charles River Deutschland, Kisslegg, Germany.
Number of animals : Experimental group: 10 females. Control group: 5 females (females were nulliparous and non-pregnant).
Age : Young adult animals (approx. 4 weeks old) were selected.
Identification : Ear tattoo.
Reliability check : The results of a reliability test performed not more than 6 months previously are summarised in the Appendix. Similar procedures were used in the reliability test and in this study.
Conditions : A controlled environment was maintained in the room with optimal conditions considered as being approximately 15 air changes per hour, a temperature of 21°C, a relative humidity of 50% and 12 hours artificial fluorescent light and 12 hours dark per day. Deviations from these optimal conditions were noted, but were considered not to have affected study integrity.
Accommodation : Group housing of 5 animals per labelled metal cage with wire-mesh floors. The acclimatisation period was at least 5 days before the start of treatment under laboratory conditions.
Diet : Free access to standard guinea pig diet, including ascorbic acid (1000 mg/kg); (Charles River Breeding and Maintenance Diet for Guinea Pigs, Altromin, Lage, Germany). Certificates of analysis were examined and retained in the NOTOX archives. Hay (B.M.I., Helmond, The
Netherlands) was provided once a week.
Water : Free access to tap water. Certificates of quarterly analysis for tap-water were examined and retained in the NOTOX archives. - Route:
- intradermal
- Vehicle:
- corn oil
- Concentration / amount:
- 1 % in corn oil for intradermal induction, 20 % for the epidermal challenge
- Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- 1 % in corn oil for intradermal induction, 20 % for the epidermal challenge
- No. of animals per dose:
- Experimental group: 10 females.
Control group: 5 females. - Details on study design:
- INDUCTION - Experimental animals:
Day 1 : The scapular region was clipped and three pairs of intradermal injections (0.1 ml/site) were made in this area as follows:
A) A 1:1 w/w mixture of Freunds' Complete Adjuvant (Difco, Detroit, U.S.A.) with water for injection (Fresenius AG, Bad Homburg, Germany).
B) The test substance at a 1 % concentration.
C) A 1:1 w/w mixture of the test substance, at twice the concentration used in (B) and Freunds' Complete Adjuvant.
Note: One of each pair was on each side of the midline and from cranial A) to caudal C).
Day 3 : The dermal reactions caused by the intradermal injections were assessed for irritation.
Day 8 : The scapular area between the injection sites was clipped and subsequently treatedwith 0.5 ml of a 100% test sUbstance concentration using a Metalline patch (2x3 cm) mounted on Medical tape, which was held in place with Micropore tape and subsequently Coban elastic bandage. The dressing was removed after 48 hours exposure, the skin cleaned of residual test substance using water and the dermal reactions caused by the epidermal exposure were assessed for irritation.
INDUCTION - Control animals:
The control animals were treated as described for the experimental animals except that, instead of the test substance, vehicle alone was administered.
CHALLENGE - All animals:
Day 22 : One flank of all animals was clipped and treated by epidermal application of a 20% test substance concentration and the vehicle (0.15 ml each), using Patch Test Plasters (Leukotest ®, Beiersdorf Medical, Almere, The Netherlands). The patches were held in place with Micropore tape and subsequently Coban elastic bandage. The dressing was removed after 24 hours exposure and the skin cleaned of residual test substance and vehicle using water. The treated sites were assessed for challenge reactions 24 and 48 hours after removal of the dressing.
Grading Irritation Reactions:
Erythema and eschar formation:
No erythema 0
Slight erythema (barely perceptible) 1
Well-defined erythema 2
Moderate erythema 3
Severe erythema (beet redness) to slight eschar formation (injuries in depth) 4
Oedema formation:
No oedema 0
Slight oedema (barely perceptible) 1
Well-defined oedema (edges of area well-defined by definite raising) 2
Moderate oedema (raised approximately 1 mm) 3
Severe oedema (raised more than 1 mm and extending beyond the area of exposure) 4
(Intradermal reactions were assessed for erythema only or, if necrosis is present the diameter of necrosis.)
Grading Challenge Reactions:
No visible change 0
Discrete or patchy erythema 1
Moderate and confluent erythema 2
Moderate erythema and swelling 3
Intense erythema and swelling 4 - Positive control substance(s):
- yes
- Remarks:
- ALPHA-HEXYLCINNAMIC ALDEHYDE was tested in an independent study as reliability check of the test system
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: none.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 20 %
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 20 %. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 20 %
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 20 %. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: none.
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: other: CLP, EU GHS (Regulation (EC) No 1272/2008)
- Conclusions:
- The skin reactions observed in response to a 20% test substance concentration in all (of the ten) experimental animals in the challenge phase were considered indicative of sensitisation, based on the absence of any response in the control animals. These results indicate a sensitisation rate of 100 per cent.
Based on these results and according to the EC criteria for classification and labelling requirements for dangerous substances and preparations (Guidelines in Commission Directive 93/21/EEC), ZINN(II)-RICINOLEAT should be labelled as: may cause sensitisation by skin contact (R 43). - Executive summary:
Assessment for Contact Hypersensitivity to ZINN(II)-RICINOLEAT in the Albino Guinea Pig (Maximisation Test).
The study was carried out based on the guidelines described in: EC Commission Directive 96/54/EC, Part B.6, "Skin Sensitisation" and OECD No. 406, "Skin Sensitisation", and based on the method described by Magnusson and Kligman, "Allergic Contact Dermatitis in the Guinea Pig - Identification of Contact Allergens". Test substance concentrations selected for the main study were based on the results of a preliminary study. In the main study, ten experimental animals were intradermally injected with a 1 % concentration and epidermally exposed to a 100% concentration. Five control animals were similarly treated, but with vehicle alone (corn oil). Two weeks after the epidermal application all animals were challenged with a 20% test substance concentration and the vehicle. In the challenge phase, skin reactions varying between grades 1 and 2 were observed in all experimental animals in response to the 20% test substance concentration. No skin reactions were evident in the control animals. Scaliness was seen in some treated skin sites among the experimental animals. The skin reactions observed in response to a 20% test substance concentration in all (of the ten) experimental animals in the challenge phase were considered indicative of sensitisation, based on the absence of any response in the control animals. These results indicate a sensitisation rate of 100 per cent.
Reference
Challenge readings:
Animal number |
Day 24 |
Day 25 |
Comments |
||
20 % * |
Vehicle ** |
20 % * |
Vehicle ** |
|
|
Control |
|
|
|
|
|
51 |
0 |
0 |
0 |
0 |
|
52 |
0 |
0 |
0 |
0 |
|
53 |
0 |
0 |
0 |
0 |
|
54 |
0 |
0 |
0 |
0 |
|
55 |
0 |
0 |
0 |
0 |
|
Experimental |
|
|
|
|
|
56 |
1 |
0 |
1 |
0 |
sensitized |
57 |
1 |
0 |
1p |
0 |
sensitized |
58 |
2 |
0 |
1 |
0 |
sensitized |
59 |
2 |
0 |
2p |
0 |
sensitized |
60 |
1 |
0 |
1 |
0 |
sensitized |
61 |
1 |
0 |
2 |
0 |
sensitized |
62 |
1 |
0 |
1 |
0 |
sensitized |
63 |
1 |
0 |
1 |
0 |
sensitized |
64 |
1 |
0 |
1 |
0 |
sensitized |
65 |
2 |
0 |
2p |
0 |
sensitized |
* test substance concentration
** corn oil
P = scaliness
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
In a dermal sensitization study according to OECD guideline 406 with ZINN(II)-RICINOLEAT, guinea pigs were tested using the method of Magnusson and Kligman.
In the main study, ten experimental animals were intradermally injected with a 1 % concentration and epidermally exposed to a 100% concentration. Five control animals were similarly treated, but with vehicle alone (corn oil). Two weeks after the epidermal application all animals were challenged with a 20% test substance concentration and the vehicle.
Skin reactions varying between grades 1 and 2 were observed in all experimental animals at the 24 and 48 hour readings. No skin reactions were evident in the control animals.
The skin reactions observed in response to a 20% test substance concentration in all (of the ten) experimental animals in the challenge phase were considered indicative of sensitisation, based on the absence of any response in the control animals.
Migrated from Short description of key information:
Sensitising in the Guinea Pig Maximisation Test (OECD TG 406)
Justification for selection of skin sensitisation endpoint:
Data from a GLP compliant guideline study with reliability 1.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on a sensitization rate of 100 % and a intradermal induction dose of 1 % in the Guinea pig maximisation study according to OECD guideline 406 (Magnusson and Kligman) ZINN(II)-RICINOLEAT has to be regarded as skin sensitizer; the sub-category 1A has to be assigned.
The following classification and labeling is required:
· according to CLP, EU GHS (Regulation (EC) No 1272/2008, 4thATP):
Skin sensitization Cat. 1A, H 317 (may cause an allergic skin reaction)
· according to Directive 67/548/EEC:
Sensitizing, R43 (may cause sensitisation by skin contact)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.